HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hermann-Josef Gröne Selected Research

Globosides

10/2014Depletion of globosides and isoglobosides fully reverts the morphologic phenotype of Fabry disease.
9/2012Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hermann-Josef Gröne Research Topics

Disease

30Fibrosis (Cirrhosis)
04/2022 - 06/2001
25Inflammation (Inflammations)
11/2019 - 02/2001
21Neoplasms (Cancer)
09/2021 - 06/2002
16Glomerulonephritis
08/2021 - 05/2001
12Proteinuria
11/2021 - 05/2001
12Albuminuria
11/2018 - 05/2001
8Kidney Diseases (Kidney Disease)
08/2021 - 04/2008
8Diabetic Nephropathies (Diabetic Nephropathy)
10/2019 - 01/2003
8Infections
11/2017 - 09/2002
7Heart Failure
01/2019 - 11/2004
6Body Weight (Weight, Body)
08/2014 - 08/2003
5Type 2 Diabetes Mellitus (MODY)
01/2019 - 01/2003
5Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2017 - 03/2005
5Hypertrophy
10/2014 - 05/2000
5Lupus Nephritis
12/2011 - 03/2004
5Hypertension (High Blood Pressure)
06/2010 - 05/2000
5Ureteral Obstruction
09/2009 - 06/2001
4Membranous Glomerulonephritis (Membranous Nephropathy)
08/2021 - 01/2002
4Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
04/2021 - 01/2002
4Diabetes Mellitus
01/2020 - 01/2003
4Renal Insufficiency (Renal Failure)
01/2019 - 02/2001
4Nephritis
01/2018 - 04/2002
4Reperfusion Injury
10/2014 - 06/2004
4Vasculitis (Vasculitides)
12/2010 - 12/2001
4Prostatic Neoplasms (Prostate Cancer)
06/2008 - 06/2002
3IGA Glomerulonephritis (IGA Nephropathy)
08/2021 - 05/2003
3Atrophy
01/2021 - 03/2002
3Carcinoma (Carcinomatosis)
12/2017 - 02/2007
3Fabry Disease (Fabry's Disease)
10/2017 - 09/2012
3Sclerosis
06/2017 - 04/2002
3Hepatitis C
01/2017 - 02/2006
3Lung Neoplasms (Lung Cancer)
01/2017 - 08/2004
3Wilms Tumor (Wilm's Tumor)
09/2015 - 11/2003
3Obesity
02/2015 - 05/2010
3Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
12/2014 - 01/2002
3Nephrotic Syndrome (Syndrome, Nephrotic)
12/2014 - 12/2004
3Iron Overload
08/2014 - 01/2004
3Necrosis
04/2013 - 09/2009
3Interstitial Nephritis (Tubulointerstitial Nephritis)
02/2012 - 08/2009
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2010 - 03/2004
3Iron Deficiencies
08/2010 - 01/2004
2Anemia
11/2021 - 03/2008
2Colonic Neoplasms (Colon Cancer)
09/2021 - 11/2007
2Thrombotic Microangiopathies
08/2021 - 09/2002
2Hyperglycemia
01/2021 - 03/2013
2Pulmonary Hypertension
01/2021 - 11/2004
2Insulin Resistance
01/2020 - 05/2010
2Chronic Kidney Failure (Chronic Renal Failure)
04/2019 - 07/2008
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019 - 01/2003

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
01/2016 - 05/2000
11ChemokinesIBA
01/2018 - 05/2001
9Messenger RNA (mRNA)IBA
02/2006 - 01/2002
8CreatinineIBA
10/2019 - 01/2003
8DNA (Deoxyribonucleic Acid)IBA
11/2017 - 06/2002
7Antigen-Antibody Complex (Immune Complex)IBA
01/2018 - 05/2001
7Chemokine CCL5IBA
08/2007 - 05/2001
6CytokinesIBA
04/2022 - 05/2005
6LigandsIBA
10/2014 - 06/2003
6Pharmaceutical PreparationsIBA
08/2013 - 01/2002
5GlycosphingolipidsIBA
09/2021 - 05/2010
5Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2021 - 10/2014
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2010 - 01/2003
5Chemokine ReceptorsIBA
02/2004 - 05/2001
4Glycoproteins (Glycoprotein)IBA
11/2021 - 04/2007
4EnzymesIBA
09/2021 - 06/2004
4Glucose (Dextrose)FDA LinkGeneric
01/2020 - 05/2010
4LipidsIBA
01/2016 - 10/2011
4Transcription Factors (Transcription Factor)IBA
09/2015 - 01/2006
4IronIBA
08/2014 - 01/2004
4AntigensIBA
01/2012 - 11/2003
4BiglycanIBA
12/2011 - 08/2004
3Glucosylceramides (Glucocerebrosides)IBA
01/2019 - 10/2013
3AlbuminsIBA
01/2019 - 01/2003
3GalactosidasesIBA
10/2017 - 09/2012
3Prednisolone (Predate)FDA LinkGeneric
05/2017 - 03/2008
3GlucocorticoidsIBA
05/2017 - 02/2007
3Sulfoglycosphingolipids (Sulfatides)IBA
11/2014 - 11/2007
3CC ChemokinesIBA
10/2014 - 06/2001
3Endothelin-1 (Endothelin 1)IBA
09/2014 - 05/2000
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2012 - 11/2001
3LipopolysaccharidesIBA
01/2012 - 09/2009
3Transforming Growth Factor beta1 (TGF beta 1)IBA
08/2010 - 03/2002
3Matrix Metalloproteinases (MMPs)IBA
06/2010 - 09/2004
3RNA (Ribonucleic Acid)IBA
05/2005 - 06/2002
3BX 471IBA
12/2004 - 01/2002
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
08/2021 - 12/2011
2SodiumIBA
01/2021 - 06/2007
2Retinaldehyde (Retinal)IBA
01/2021 - 02/2010
2Blood Glucose (Blood Sugar)IBA
01/2020 - 02/2015
2Insulin (Novolin)FDA Link
01/2020 - 02/2015
2Galactosylceramides (Galactocerebrosides)IBA
11/2019 - 01/2017
2NPHS2 proteinIBA
01/2019 - 11/2003
2nephrinIBA
01/2019 - 11/2003
2Chemokine Receptor D6IBA
01/2019 - 01/2018
2Biomarkers (Surrogate Marker)IBA
01/2019 - 06/2017

Therapy/Procedure

23Therapeutics
01/2021 - 11/2001
6Transplantation
11/2021 - 08/2003
5Radiotherapy
01/2017 - 03/2005
5Drug Therapy (Chemotherapy)
07/2013 - 03/2005
2Injections
01/2019 - 06/2003